Endotoxin and CD14 in the progression of biliary atresia
2010

Endotoxin and CD14 in Biliary Atresia

Sample size: 41 publication Evidence: moderate

Author Information

Author(s): Chou Ming-Huei, Chuang Jiin-Haur, Eng Hock-Liew, Chen Ching-Mei, Wang Chiou-Huey, Chen Chao-Long, Lin Tsun-Mei

Primary Institution: National Chang Kung University

Hypothesis

The study investigates the relationship between endotoxin levels and CD14 expression in patients with biliary atresia.

Conclusion

The study found that plasma endotoxin and soluble CD14 levels are significantly altered in biliary atresia, suggesting a role in liver injury.

Supporting Evidence

  • Plasma sCD14 levels were significantly higher in early-stage biliary atresia compared to late-stage.
  • Endotoxin levels were significantly higher in both early and late stages of biliary atresia compared to controls.
  • The study used a rat model to confirm the increase in CD14 expression following bile duct ligation.

Takeaway

This study looks at how a substance called endotoxin and a protein called CD14 are related in babies with a liver problem called biliary atresia.

Methodology

The study measured plasma levels of endotoxin and soluble CD14 using specific assays in patients with different stages of biliary atresia.

Potential Biases

Potential biases may arise from the selection of patients and the methods used for measuring endotoxin and CD14 levels.

Limitations

The study may have limited generalizability due to the specific patient population and sample size.

Participant Demographics

The study included 41 patients with early-stage biliary atresia, 25 jaundice-free patients post-Kasai procedure, and 49 patients with late-stage biliary atresia.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-5876-8-138

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication